Literature DB >> 1645969

Antireactive properties of glucosamine sulfate.

I Setnikar1, R Cereda, M A Pacini, L Revel.   

Abstract

Glucosamine (CAS 3416-24-8) is an aminomonosaccharide naturally occurring in the human body. It was tested for antiinflammatory activities and it showed to protect against the edema provoked in the rat paw by carrageenin, dextran, formalin, but not against the edema provoked by specific inflammation mediators, such as bradykinin, serotonin, histamine. Glucosamine protected against pleurities provoked in the rat by carrageenin, but not against that provoked by bradykinin. Furthermore glucosamine protected against peritonitis provoked in the rat by formalin and in the mouse by acetic acid. Glucosamine did not show antinoceptive properties against writings provoked by i.p. phenylquinone in the mouse. Glucosamine did not show inhibiting activities on cyclooxygenase or on the proteolytic enzymes in the inflamed paw of the rat, but it was able to inhibit in vitro superoxide generation and lysosomial enzymes of the liver. The potency of glucosamine on the antiinflammatory tests was lower than that of acetylsalicylic acid and much lower than that of indomethacin. Its acute toxicity, however, and notably the toxicity on the gastrointestinal tract is very low, practically absent. The pharmacological therapeutic index of glucosamine with regard to the antiinflammatory activities seems therefore comparable or superior to that of the known non-steroidal anti-inflammatories.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645969

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  12 in total

Review 1.  Evidence of nutriceutical effectiveness in the treatment of osteoarthritis.

Authors:  J Y Reginster; V Gillot; O Bruyere; Y Henrotin
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

2.  Do glucosamine and chondroitin treat the symptoms of osteoarthritis?

Authors:  D D Edelist; M F Evans
Journal:  Can Fam Physician       Date:  2001-02       Impact factor: 3.275

Review 3.  The use of glucosamine therapy in osteoarthritis.

Authors:  Djamila Zerkak; Maxime Dougados
Journal:  Curr Pain Headache Rep       Date:  2004-12

Review 4.  Glucosamine: a review of its use in the management of osteoarthritis.

Authors:  Anna J Matheson; Caroline M Perry
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Specialty supplement use and biologic measures of oxidative stress and DNA damage.

Authors:  Elizabeth D Kantor; Cornelia M Ulrich; Robert W Owen; Peter Schmezer; Marian L Neuhouser; Johanna W Lampe; Ulrike Peters; Danny D Shen; Thomas L Vaughan; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-05       Impact factor: 4.254

Review 6.  The use of glucosamine therapy in osteoarthritis.

Authors:  Djamila Zerkak; Maxime Dougados
Journal:  Curr Rheumatol Rep       Date:  2004-02       Impact factor: 4.592

7.  Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.

Authors:  Heather Greenlee; Katherine D Crew; Theresa Shao; Grace Kranwinkel; Kevin Kalinsky; Matthew Maurer; Lois Brafman; Beverly Insel; Wei Yann Tsai; Dawn L Hershman
Journal:  Support Care Cancer       Date:  2012-11-01       Impact factor: 3.603

Review 8.  Role of glucosamine in the treatment for osteoarthritis.

Authors:  Jean-Yves Reginster; Audrey Neuprez; Marie-Paule Lecart; Nathalie Sarlet; Olivier Bruyere
Journal:  Rheumatol Int       Date:  2012-03-30       Impact factor: 2.631

9.  Comparison of glucose derivatives effects on cartilage degradation.

Authors:  Thanyaluck Phitak; Peraphan Pothacharoen; Prachya Kongtawelert
Journal:  BMC Musculoskelet Disord       Date:  2010-07-15       Impact factor: 2.362

10.  A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis.

Authors:  Tamil Selvan; Kingston Rajiah; M Sundara-Moorthi Nainar; Elizabeth M Mathew
Journal:  ScientificWorldJournal       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.